Mora and colleagues showed that cidofovir treatment was able to reduce fibrotic disease in the MHV68 infected IFNγR-/- C57Bl/6 with treatment given as late as 60 days post infection- well after the onset of fibrotic disease [15]. This evidence concerns the gene IFNGR1 and infection.